Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tudor Arvinte

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical Sciences|March 5, 2011
Noncovalent pegylation by dansyl-poly(ethylene glycol)s as a new means against aggregation of salmon calcitoninClaudia Mueller, Martinus A H Capelle, Tudor Arvinte, et al.
Journal of Drug Targeting|July 14, 2009
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activityAngelica Vargas, Norbert Lange, Tudor Arvinte, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 8, 2011
Enhanced physical stability of human calcitonin after methionine oxidationFilippo Mulinacci, Emilie Poirier, Martinus A H Capelle, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 21, 2013
Influence of methionine oxidation on the aggregation of recombinant human growth hormoneFilippo Mulinacci, Emilie Poirier, Martinus A H Capelle, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 28, 2011
Tryptophan-mPEGs: novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylationClaudia Mueller, Martinus A H Capelle, Tudor Arvinte, et al.
Biochimica Et Biophysica Acta|December 5, 2006
Characterization of protein aggregation: the case of a therapeutic immunoglobulinBarthélemy Demeule, M Jayne Lawrence, Alex F Drake, et al.
Journal of Pharmaceutical Sciences|January 21, 2011
Stability of human growth hormone: influence of methionine oxidation on thermal foldingFilippo Mulinacci, Martinus A H Capelle, Robert Gurny, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 14, 2023
Aggregation of human plasma and of human blood induced in vitro by filgrastim originator product; effect of PEGylationTudor Arvinte, Emilie Poirier, Amelia Cudd, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2019
Part 1: Physicochemical characterization of bevacizumab in undiluted 25 mg/mL drug product solutions: Comparison of originator with a biosimilar candidateTudor Arvinte, Caroline Palais, Emilie Poirier, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 26, 2019
Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidateTudor Arvinte, Caroline Palais, Emilie Poirier, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|March 5, 2011
Noncovalent pegylation by dansyl-poly(ethylene glycol)s as a new means against aggregation of salmon calcitoninClaudia Mueller, Martinus A H Capelle, Tudor Arvinte, et al.
Journal of Drug Targeting|July 14, 2009
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activityAngelica Vargas, Norbert Lange, Tudor Arvinte, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 8, 2011
Enhanced physical stability of human calcitonin after methionine oxidationFilippo Mulinacci, Emilie Poirier, Martinus A H Capelle, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 21, 2013
Influence of methionine oxidation on the aggregation of recombinant human growth hormoneFilippo Mulinacci, Emilie Poirier, Martinus A H Capelle, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 28, 2011
Tryptophan-mPEGs: novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylationClaudia Mueller, Martinus A H Capelle, Tudor Arvinte, et al.
Biochimica Et Biophysica Acta|December 5, 2006
Characterization of protein aggregation: the case of a therapeutic immunoglobulinBarthélemy Demeule, M Jayne Lawrence, Alex F Drake, et al.
Journal of Pharmaceutical Sciences|January 21, 2011
Stability of human growth hormone: influence of methionine oxidation on thermal foldingFilippo Mulinacci, Martinus A H Capelle, Robert Gurny, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 14, 2023
Aggregation of human plasma and of human blood induced in vitro by filgrastim originator product; effect of PEGylationTudor Arvinte, Emilie Poirier, Amelia Cudd, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2019
Part 1: Physicochemical characterization of bevacizumab in undiluted 25 mg/mL drug product solutions: Comparison of originator with a biosimilar candidateTudor Arvinte, Caroline Palais, Emilie Poirier, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 26, 2019
Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidateTudor Arvinte, Caroline Palais, Emilie Poirier, et al.
Pageof 4